Cargando…
Targeting hypoxia in tumor: a new promising therapeutic strategy
Low oxygen condition (hypoxia) is considered a hallmark of rapidly growing solid tumors. The presence of hypoxia renders tumor cells resistant to conventional chemo- and radio-therapy selecting a more malignant and invasive phenotype, and playing a negative role in patient prognosis. This commentary...
Autores principales: | Bosco, Maria Carla, D’Orazi, Gabriella, Del Bufalo, Donatella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953227/ https://www.ncbi.nlm.nih.gov/pubmed/31924239 http://dx.doi.org/10.1186/s13046-019-1517-0 |
Ejemplares similares
-
Correction to: Targeting hypoxia in tumor: a new promising therapeutic strategy
por: Bosco, Maria Carla, et al.
Publicado: (2020) -
Nobel committee honors tumor immunologists
por: Rotte, Anand, et al.
Publicado: (2018) -
Targeting mutant p53 in cancer: the latest insights
por: Di Agostino, Silvia, et al.
Publicado: (2019) -
HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases
por: Garufi, Alessia, et al.
Publicado: (2023) -
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
por: Pistritto, Giuseppa, et al.
Publicado: (2016)